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The influence of developmental stage and position (top, middle, and base) of leaves and
stem tissues on the expression and glycosylation pattern of a recombinant therapeutic
protein -GA733-FcK- was observed in transgenic seedlings during a 16-week growth
period. RNA expression gradually increased with age in the middle and basal leaves and
decreased in top leaves after 14 weeks. The protein expression level at all leaf positions
increased until 14 weeks and slightly decreased at 16 weeks; it was lower in yellow
leaves than in green leaves. In stem, protein expression gradually decreased from the
top to the base. The glycosylation patterns of GA733-FcK were analyzed from 10 to
16 weeks. The plant-specific glycans increased in the top leaves at 14 weeks, but only
slightly changed in the middle and basal leaves. The structure of glycans varied with tissue
position. The glycosylation level in the top and middle leaves increased until 12 and 14
weeks, respectively, and decreased thereafter, whereas it decreased in basal leaves until
14 weeks and increased at 16 weeks. In stem, all three sections showed high-mannose
type glycan structures. The area size of the glycans was significantly higher in the top stem
than in both the middle and basal stems, and it was smaller in yellow leaves than in green
leaves. The glycan profiles were similar between green and yellow leaves until 16 weeks.
Thus, biomass-harvesting time should be optimized to obtain recombinant therapeutic
proteins with ideal glycan structure profiles.
Keywords: N-glycosylation, developmental stage, tissue position, transgenic plant, GA733-FcK, recombinant
glycoprotein
INTRODUCTION
Plants have been considered a promising bio-organism for pro-
duction of highly valuable recombinant prophylactic and thera-
peutic proteins because of the overall cost effective production,
post-translational adjustment, and glycosylation that is similar to
that of mammalian cells (Rigano and Walmsley, 2005; Daniell
et al., 2009). It is often claimed that production of highly valu-
able, plant-derived recombinant proteins in a plant needs only
simple inputs (sunlight, water, and nutrients) that will enable
the plant’s rapid increase in biomass. Environmental factors that
affect production of the plant biomass include temperature, light,
salinity, drought, nutrition, insects, and pests (Criddle et al., 1997;
Elbers et al., 2001; Jamal et al., 2013). The degree of recombi-
nant gene expression varies in accordance with the increasing
environmental factors such as temperature, day length, compost
nitrogen content, nutrients, radiation, and plant density, which
in turn affect the cultivation conditions of plants (Stevens et al.,
2000; Elbers et al., 2001). Aging and position of tissues determine
both the quality and quantity of recombinant protein produced
in transgenic plants. Thus, the harvesting time and location of the
high biomass tissues should be optimized to obtain recombinant
therapeutic proteins with ideal glycan structure profiles.
In our previous study, the colorectal cancer vaccine candidate
GA733-Fc recombinant protein was successfully expressed in a
transgenic plant. GA733 is an epithelial cell adhesion molecule
that is abundant in colorectal cancer cells. The extracellular
domain of GA733 is often used as a target for cancer vaccina-
tion (Lu et al., 2012). A plant-derived recombinant GA733-Fc
fused to KDEL endoplasmic reticulum (ER) retention signal was
confirmed to have vaccine-like efficacy in animals. The antigen-
antibody complex GA733-FcK may potentially have properties
similar to the parental IgG, including enhanced efficacy of vac-
cination by targeting the vaccine to antigen-presenting cells,
facilitated purification by the protein-A method, and increased
half-life (Lu et al., 2012). To obtain such a highly valuable recom-
binant antigen-antibody complex proteins with high expression
levels, better yields of plant biomass should be established in plant
expression systems (Lo et al., 1998; Flanagan et al., 2007; Lu et al.,
2012). However, how the tissue position and aging of a plant
affect the glycan structure and protein expression level has not
been investigated. Most of therapeutic proteins are glycoproteins,
containing glycans with crucial roles in protein folding, thera-
peutic efficacy, in vivo half-lives, and immunogenicity (Lee et al.,
2013). Glycoproteins produced from plants are not identical to
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the therapeutic proteins produced in human or mammalian cells,
and plant-specific glycoproteins of xylose and fucose may induce
an allergic reaction when administered to a human (Daniell et al.,
2001, 2009; Tekoah et al., 2004). To reduce the possibility of an
allergic reaction, the predominant expression system for thera-
peutic glycoproteins is retained in ER, which is the site of protein
glycosylation, assembly, and folding (Sriraman et al., 2004). Thus,
in this study, a variation of the GA733-FcK expression and its
N-glycan structure were investigated in plant tissues at different
locations and growth stage. The location and age of the tissues
influence both the quality and quantity of recombinant proteins
produced in transgenic plants (Stevens et al., 2000; Valdes et al.,
2003a; Jamal et al., 2009). The objectives of this study were to
investigate the effect of the developmental stage and position of
plant leaves and tissues along the stem on expression and glycosy-
lation of the recombinant GA733-FcK protein, and to determine
the best harvesting time and tissue position for high protein
expression and ideal glycosylation.
MATERIALS AND METHODS
PLANT MATERIAL
The GA733-FcK gene was cloned under the control of the
enhanced cauliflower mosaic virus (CaMV) 35S promoter and
tobacco etch viral 5′-leader sequence (TEV). Seedlings of trans-
genic tobacco (Nicotiana tabacum) line 303 seedlings highly
expressing the tumor-associated antigen against GA733-FcK
recombinant therapeutic proteins (Lu et al., 2012) were trans-
planted and grown in soil pots for 18 weeks in a greenhouse.
Two hundred plants were used in the plant growth analysis. The
leaf length was measured on the largest leaf, and plant height was
measured from the base of the plant stem to the uppermost leaf.
The position of leaves along the stem was divided into three equal
sections: top, middle, and base, and leaf samples were collected
from the top, middle, and base of the transgenic tobacco plant.
Leaves were harvested at the age of 10, 12, 14, and 16 weeks after
transplanting. Stem sections (top, middle, and base), including
yellow and green leaves, were harvested at the age of 18 weeks.
RNA ISOLATION AND QUANTITATIVE REAL-TIME PCR ANALYSIS
The transcription level of GA733-FcK was quantified with a real-
time (RT)-PCR. Total RNA was extracted from transgenic plant
samples (top, middle, base) using an RNeasy Plant Mini Kit
(Qiagen, Valencia, CA, USA) according to the manufacturer’s
protocol. At least 10 plants for each developmental stage and tis-
sue positions were used for real-time PCR analysis. To remove the
genomic DNA, 400 ng of total RNA was treated using a TURBO
DNA-free kit (Ambion, Austin, TX, USA) in a reaction volume
of 20μL, and the isolated RNA samples were stored at −80◦C
until further use. Each RNA sample was used as a template in RT-
PCR reactions performed using GoScript™ Reverse Transcription
System (Promega, Madison, WI, USA) and GA733-FcK specific
forward 5′-ATCTGGATCCTGGTCAAA-3′ and reverse primer 5′-
CTCAGAGCAGGTTATTTC A-3′. PCR reactions (25μL) con-
tained 12.5μL SYBRGreen PCRMaster Mix (Promega, Madison,
WI, USA), 4μL cDNA solution (equivalent to∼100 ng template),
and primers at final concentrations of 1.0μM. PCR was per-
formed using a real-time PCR machine (Rotor-Gene Q, Qiagen)
with the following cycling parameters: 5min at 95◦C, 5 s at 95◦C,
10 s at 60◦C, and 40 cycles of 5 s at 95◦C and 10 s at 60◦C.
PCR reactions containing cDNA or “no template” control (NTC;
containing only RNase-free water) were run in parallel for each
template and primer combination. In qPCR analysis, the EF-
1α gene involved in plant growth was used as a reference gene.
Real-time PCR analysis was performed for more than 3 times.
IMMUNOBLOT ANALYSIS
At least 10 plants for analysis each developmental stage and tis-
sue positions were used for immunoblot blot. All samples were
used with the same fresh weight of leaves and stems. Hundred
milligrams of fresh leaves and stems (top, middle, and base)
were homogenized in 350μL 1 × PBS (137mM NaCl, 10mM
Na2HPO4, 2.7mM KCl, and 2mM KH2PO4) to extract the total
soluble proteins. A volume of 20μL of extracted sample (100mg
of fresh leaf/300μL) was mixed with 4μL of loading buffer (1M
Tris-HCl, 50% glycerol, 10% SDS, 5% 2-mercaptoethanol, 0.1%
bromophenol blue), loaded in 10% SDS-PAGE, and transferred
to a nitrocellulose membrane (Millipore Corp., Billerica, MA,
USA). Membranes were blocked with 5% skim milk (Sigma, St.
Louis, MO, USA) in 1 × PBS-T buffer (1 × PBS plus 0.5% [v/v]
Tween 20) for 2 h at room temperature. The blots were incu-
bated for 1 h 30min at room temperature with goat anti-human
Fcγ recognizing the Fc portion of GA733-FcK. The protein bands
were detected using “SuperSignal” chemiluminescence substrate
(Pierce, Rockford, IL, USA) and visualized by exposing the mem-
brane to an X-ray film (Fuji, Tokyo, Japan). The purified GA733-
FcK was used as a positive control. Immunoblot analysis was
performed for more than 3 times. The detected protein bands
were digitized to an electronic image, and the band intensity was
measured using Image J software (National Institutes of Health,
Bethesda, MD). To quantify [ng/(mg of fresh leaf)] the amount
of GA733-FcK in transgenic plants, the positive control (31.25,
62.5, 125, 250, and 500 ng) were loaded onto one SDS-PAGE gel
(Supplemental Data Sheet 3). The intensity of each sample and
standard was adjusted by subtracting background intensity from
the measured intensity. A standard curve between the amount
(ng) of the positive control and the measured image intensity
of the standard was calculated using Image J software (National
Institutes of Health, Bethesda, MD). The intensity value was used
to estimate the amount of GA733-FcK proteins (ng/mg) from the
linear regression equation derived from the standards.
PURIFICATION OF RECOMBINANT PROTEIN GA733-FcK FROM
TRANSGENIC PLANTS
At least 10 plants for each developmental stage and tissue
positions were used for purification. For purification of plant
GA733-FcK, tobacco plant leaves or stems were homogenized
in an HR2094 aluminum blender (Philips, Seoul, Korea) on ice
with extraction buffer (37.5mM Tris-HCl pH 7.5, 50mM NaCl,
15mM EDTA, 75mM sodium citrate, and 0.2% sodium thio-
sulfate). After centrifugation at 8800× g for 30min at 4◦C, the
suspension was filtered through aMiracloth (Biosciences, La Jolla,
CA, USA) and its pH was adjusted to 5.1 by addition of acetic acid
pH 2.4. The solution was centrifuged at 10,200× g for 30min at
4◦C. The pH of the solution was brought back to 7.0 by addition
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of 3M Tris-HCl, and ammonium sulfate was added to 8% sat-
uration. After centrifugation at 8,800× g for 30min at 4◦C, the
precipitate was discarded and ammonium sulfate was added to
the supernatant to 40% saturation. After an overnight incubation
at 4◦C, the solution was again centrifuged, the pellet was resus-
pended in extraction buffer to 1/10 of the original volume, and
the final solution was then centrifuged at 10,200× g for 30min
at 4◦C. The supernatant of extracted sample was then filtered
through a 0.45-mm filter and loaded onto a HiTrap Protein G
column (Pharmacia, Uppsala, Sweden). Soluble protein extract
was applied to a protein G column (GE Healthcare, Piscataway,
NJ, USA). Elutes of plant-derived recombinant GA733-Fc pro-
tein were dialyzed against 1 × PBS buffer. Aliquots were frozen
in liquid nitrogen and stored at −80◦C for glycosylation analysis
(Supplemental Data Sheet 2).
GLYCAN ANALYSIS
The purified samples were incubated twice with 2μL of pepsin
in an incubator at 37◦C for 12 h to digest the protein into gly-
copeptides. The digested glycopeptides were collected using a C18
sep-pak cartridge (Waters, Lexington, MA, USA). Briefly, samples
were passed through a C18 sep-pak cartridge and washed with 5%
acetic acid to remove contaminants such as salts and free sugar.
The fraction containing peptides and glycopeptides was eluted in
a series of solutions with 20% iso-propanol in 5% acetic acid, 40%
iso-propanol in 5% acetic acid, and 100% iso-propanol, and the
eluted fractions were dried in a speed vacuum system. PNGase A
(Roche, Basel, Switzerland) was added to the samples to release
N-glycans, and the samples were incubated overnight at 37◦C.
The released N-glycans were purified from the samples by using
a graphitized carbon resin from Carbograph (Alltech, Lexington,
MA, USA).
HPLC ANALYSIS OF AB LABELED GLYCANS
For detection in HPLC, purified glycans were aminobenzamide
(AB)-labeled using previously described methods with slight
modifications (Bigge et al., 1995). Briefly, the labeling reagent was
freshly prepared by dissolving 6mg of AB in 100μL 30% (v/v)
acetic acid in a dimethyl sulfoxide solution containing 1M of
sodium cyanoborohydride. Then, each dried glycan sample was
dissolved in 5μL of a labeling reagent and incubated overnight in
a tightly capped tube at 37◦C. The mixture was diluted with 1mL
of 96% (v/v) acetonitrile in water, and excess labeling reagent
was removed using a cyano cartridge (Agilent Technologies,
Santa Clara, CA, USA) following the manufacturer’s instructions.
Purified AB-labeled glycans were separated on a TSK amide-80
(5μm, 4.6mm × 250mm) column (Tosoh Bioscience, Prussia,
PA, USA) using the previously described HPLC systems with a
fluorescence detector (330 nm excitation and 425 nm emission).
Separations were achieved at a flow rate of 1.0mL/min using a
mixture of solvent A (100% acetonitrile) and solvent B (50mM
ammonium formate, pH 4.4). After the column was equilibrated
with 30% solvent B, the sample was injected and then eluted by a
linear gradient to 45% of solvent B for 60min. HPLC analysis was
performed for more than 3 times.
STATISTICAL ANALYSIS
All data were presented as the mean ± SD. Comparisons of mul-
tiple groups were performed by One-Way analysis of variance
(ANOVA) and Two-Way ANOVA, followed by pairwise compar-
isons with a Bonferroni post-hoc test. Differences were considered
statistically significant at p < 0.05. All data were analyzed using
the GraphPad Prism software, version 5.00 (Graph-Pad software,
San Diego, CA).
RESULTS
GROWTH PATTERNS OF PLANT HEIGHT AND LEAF LENGTH
To investigate the change in plant biomass expressed through
plant height and leaf length, and the variation in expression of
GA733-FcK during the growth period under greenhouse con-
ditions, F3 seedlings of transgenic plant expressing GA733-FcK
were transplanted into soil pots and grown in a greenhouse for
18 weeks. There was no significant difference in plant height and
leaf length between transgenic plants expressing GA733-FcK and
non-transgenic plants (Figure 1). The plant height increased at
fast pace for approximately 8 weeks, and it continued increasing
until 18 weeks (Figure 1). The leaf length rapidly increased from
7 to 10 weeks and then slowly decreased. At 14 weeks, the plants
started to blossom, and at 18 weeks of fertilization and seed-
pod formation occurred. Overall, the growth patterns between
transgenic and non-transgenic plants were similar.
EFFECT OF PLANT GROWTH STAGE ON TRANSCRIPTIONAL LEVEL OF
GA733-FcK GENE
Real-time PCR was used to determine the transcriptional level
of the GA733-FcK gene in samples of top (T), middle (M), and
basal (B) leaves harvested from tobacco plants at 10, 12, 14, and
16 weeks after transplanting (Figure 2). In the top leaves, the
expression ratio increased until 14 weeks followed by a decrease.
In the middle and base leaves, the expression ratio continuously
increased until 16 weeks. However, the basal leaves did not show
rapid increase in expression ratio compared to the middle leaves.
EFFECT OF PLANT GROWTH STAGE ON GA733-FcK PROTEIN LEVEL IN
LEAVES
The changes in GA733-FcK protein levels in top, middle, and
basal leaves at 10, 12, 14, and 16 weeks after transplanting were
investigated by western blotting (Figure 3). In the top leaves, the
GA733-FcK protein level increased until 12 weeks (342 ng/mg
fresh weight; FW) and decreased afterwards, whereas in the mid-
dle and basal leaves, the protein levels increased until 14 weeks
(416 and 374 ng/mg FW, respectively). The middle leaves showed
the highest GA733-FcK protein levels at 10 weeks (281 ng/mg
FW) and 14 weeks (416 ng/mg FW). However, at 14 weeks, basal
leaves showed the highest protein level. The band density of non-
specific proteins below 50 kDa was lower in the top leaves than in
the others. At 16 weeks, the basal leaves showed relatively stronger
non-specific band density than the top and middle leaves. The
amount of detected GA733-FcK protein on each lane was rela-
tively quantified with comparison of the known amount of the
positive control. The positive controls were not shown on the
Figure 3 in this manuscript.
EXPRESSION LEVEL OF GA733-FcK IN STEMS AND SENESCENT LEAVES
AT 18 WEEKS
The different expression patterns of top, middle, and basal stem
sections harvested from plants at 18 weeks were analyzed by
using the densitometry analysis (Figure 4A). The protein level
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FIGURE 1 | Plant growth over time of GA733-FcK transgenic tobacco and non-transgenic tobacco. (A) Averages of the height. (B) Averages of the leaf
length.
FIGURE 2 | Characterization of GA733-FcK RNA expression patterns by
real-time PCR. Relative expression levels of GA733-FcK with aging and at
different positions of leaf tissues by real-time PCR using cDNAs equivalent
to 400 ng of total RNA. Positive control is the isolated RNA of GA733-FcK
transgenic plant leaf (40 ng).
(ng/mg FW) was calculated by using the standard curve between
the band density of the purified GA733-FcK and their known
protein concentrations. The protein level decreased from the
top to the base of the stem (top [232 ng/mg FW], middle
[198 ng/mg FW], and base [172 ng/mg FW]) (Figure 4A). The
non-specific bands were observed below the GA733-FcK band
in all stem samples. The smallest band (∼30 kDa) (Figure 4A)
showed stronger density at the base of the stem than in
other sections of the stem. In addition, the differential expres-
sion patterns of the GA733-FcK protein levels were deter-
mined between green and yellow leaves harvested from plants
at 18 weeks (Figure 4B). The GA733-FcK protein band was
observed with several non-specific bands, which are speculated
to be proteolytically degraded protein bands. However, in yel-
low leaves, the GA733-FcK protein band was barely observed.
Densitometry quantitative analysis showed that the GA733-
FcK protein concentration (5 ng/mg FW) in yellow leaves
was 45 times lower than that (266 ng/mg FW) in the green
leaves.
GLYCOSYLATION VARIATION OF GA733-FcK AT DIFFERENT TISSUE
POSITIONS AND DIFFERENT GROWTH STAGE
The glycosylation patterns were analyzed in leaves (top, middle,
and basal) in relation to the time after transplanting (Figures 5, 6
and Table 1; Supplemental Data Sheet 1). In the top leaves,
the plant-specific glycans (Golgi type) suddenly increased at 14
weeks. The relative percentage of Golgi type glycan structures
were 36% and 20% in 14 and 16 weeks, respectively. In the middle
leaves, the percentage of plant-specific glycan structures (Golgi
type) decreased with the time. In the basal leaves, the early growth
period (10 weeks) showed the lowest level of plant-specific gly-
can structures (Golgi type) (1%). Percentage of the plant-specific
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FIGURE 3 | Western blot analysis. (A) Western blot of the top leaf
expression. (B) Western blot of the middle leaf expression. (C) Western
blot of the basal leaf expression. Leaf samples from GA733-FcK transgenic
plants were ground with extraction buffer to confirm the protein expression
levels. The GA733-FcK proteins were detected by mouse anti-human Fcγ
antibody. The graph shows relative quantitation.
glycan structures (Golgi type) slightly increased up to 11% until
14 weeks and decreased at 16 weeks. The area of N-glycan peaks
of GA733-FcK proteins isolated from the top, middle, and basal
leaves varied with the growth period (10, 12, 14, and 16 weeks)
(Figure 7). The glycan area of proteins isolated from the top leaves
was relatively smaller than those of GA733-FcK proteins isolated
from themiddle and basal leaves. In the top andmiddle leaves, the
area increased until 12 and 14 weeks, respectively, and dramati-
cally decreased thereafter. In contrast, in basal leaves, the glycan
area decreased until 14 weeks and increased at 16 weeks. The N-
glycans of GA733-FcK proteins isolated from the top, middle, and
base of the stems of tobacco plants were analyzed by high perfor-
mance liquid chromatography (HPLC) (Figure 8). All of the three
stem sections showed similar high-mannose type glycan struc-
tures. However, the glycan area size of the top section of the stems
was significantly higher than in both middle and base sections of
the stems (P < 0.001). The size of the glycan area at the middle
stem was slightly higher than at the base section of the stem. In
addition, the glycans of GA733-FcK proteins isolated from green
and yellow leaves of tobacco plants grown until 16 weeks after
transplanting were analyzed by HPLC (Figure 9). The glycan pro-
files were similar between green and yellow leaves; however, the
FIGURE 4 | Immunoblots showing protein GA733-FcK band of yellow
and green leaves and stem. (A) Western blot of the stem expression. (B)
Western blot of the green leaf and yellow leaf expression. Leaf samples
from GA733-FcK transgenic plants were ground with extraction buffer to
confirm the protein expression levels. The GA733-FcK proteins were
detected by mouse anti-human Fcγ antibody. The graph shows relative
quantitation.
overall glycan areas of the yellow leaves were slightly smaller than
the green leaves.
DISCUSSION
We demonstrated that the growth stage and tissue position
affected the expression of recombinant GA733-FcK glycoprotein
and its N-glycan structure profile in plants (Chargelegue et al.,
2000; Lowe, 2002). The GA733-FcK is a glycoprotein GA733
fused to the Fc fragment of IgG1 type human immunoglobu-
lin, which contain four and one glycosylation sites (Lu et al.,
2012). The N-terminus of GA733 was fused with a signal
peptide sequence (MATQRRANPSSLHLITVFSLLAAVVSAEVD)
from Nicotiana plumbaginifolia to be properly targeted into ER,
and the C-terminus of the Fc was fused to KDEL, the ER retention
signal that marks the proteins to be retained in ER. The consti-
tutive expression of GA733-FcK gene was under the control of a
duplicated CaMV 35S promoter (Lu et al., 2012). The F3 seedlings
of line T303 with the highest expression, which were selected for
in vitro media, were used for our current experiments. In this
study, we hypothesized that the GA733-FcK expression and its
N-glycan structure varied depending on the location of the plant
tissues and the growth age, which influence both the quantity and
quality of recombinant proteins expressed in transgenic plants.
Thus, the main goal of this study was to elucidate the effect of the
growth stage and location of plant leaves and stem tissues (top,
middle, and base) on expression of the recombinant protein and
its glycosylation, which in turn will help in optimizing the best
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FIGURE 5 | Glycosylation analysis of GA733-FcK recombinant proteins
from leaf tissues at different positions. The profiles of N-glycans released
from GA733-FcK were analyzed using HPLC profile of AB-labeled glycans.
The proposed glycan structures for each peak are designated. GlcNAc,
mannose, and xylose are depicted with black squares, white circles, and
white stars, respectively. T, top leaf; M, middle leaf; B, basal leaf.
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FIGURE 6 | The ratio of Golgi/ER type glycans of GA733-FcK in top, middle, and basal leaf tissues at 10, 12, 14, and 16 weeks after transplanting.
Table 1 | Relative amounts of N-glycan structures of GA733-FcK isolated from leaves (top, middle, and basal) of transgenic plants.
(week) Top Middle Base
10 12 14 16 10 12 14 16 10 12 14 16
Man9 2 5 10 8 9 3 3 3 4 2 3 4
Man8 26 36 22 7 26 20 19 26 33 20 12 32
Man7 63 48 22 42 53 67 65 69 55 62 66 61
Man6 4 3 3 1 5 3 6 3 3 5 7 3
GlcNAc2Man3Xyl1GlcNAc2 2 3 14 18 5 5 3 * 2 6 5 *
GlcNAc1Man3Xyl1GlcNAc2 2 3 20 17 2 1 4 * 3 4 6 *
GlcNAc2Man3GlcNAc2 1 1 9 7 0.3 * * * 0.4 * * *
The amounts are based on relative peak intensities in HPLC and expressed as a percentage of total N-glycans (%).
*Not detectable.
harvesting time and tissue position for high protein expression
and its ideal glycosylation.
For production of highly valuable recombinant therapeutic
proteins, tobacco plants have several advantages over other plants
such as highly efficient transformation, relatively short period
for mass seed production, significant leaf biomass, and easy pro-
cessing for protein purification due to soft leaf tissue (Daniell
et al., 2001; Elbers et al., 2001; Valdes et al., 2003b; Pujol et al.,
2005). However, the transgenic plant expression system can be
fully realized only when the recombinant protein production
level per unit of plant biomass is high and with good quality
(Ko and Koprowski, 2005). Thus, the plant harvesting time
and tissue positions should be optimized to obtain the highest
biomass with good quantity and quality of recombinant proteins.
In this study, leaf length and height of the plant were measured
to determine the growth and increase in biomass over time. It
was found that the growth patterns between transgenic plants and
non-transgenic plants did not differ significantly (Figure 1). The
plant height and leaf length increased rapidly at 7–8 weeks after
transplanting of the in vitro seedlings to soil pot in a greenhouse.
The plant height continued to increase until 18 weeks, whereas
the leaf length growth continuously decreased until 10 weeks
(Figure 1). It seems that the leaf length growth slowly decreased
after the flowering was initiated at 12 weeks. These results sug-
gest that the best time to harvest to obtain high plant biomass
production should be between 12 and 14 weeks for tobacco
plants.
The variation in mRNA levels of the recombinant GA733-
FcK transgene at different tissue locations during the growth
period has not been studied in detail until now. Thus, real-
time PCR was applied to investigate whether the mRNA levels
of the GA733-FcK gene changed at different tissue positions
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along the stem (top [T], middle [M], and base [B]) and in
leaves harvested at different growth periods (10, 12, 14, and 16
weeks). In the top leaves, the expression ratio increased until
14 weeks and then decreased. This decline in the mRNA lev-
els has been associated with aging and tissue position (Mullet
and Klein, 1987). In the middle and basal leaves, the GA733-
FcK mRNA levels increased with age, although the increase in
the basal leaves was not as rapid as that seen in the middle
leaves. These results indicated that the transcription levels of the
GA733-FcK gene varied with tissue position and during the plant
growth.
FIGURE 7 | N-Glycan quantification of GA733-FcK proteins isolated
from top, middle, and basal leaves. Relative N-glycan expression levels of
GA733-FcK with aging and at different positions of leaf tissues quantified
by HPLC. The area is based on the absolute value of peak intensities in
HPLC analysis.
It has been reported that recombinant protein levels dramat-
ically change in developmental stage and environmental condi-
tions (Stevens et al., 2000; Elbers et al., 2001; Valdes et al., 2003a;
Jamal et al., 2009). Thus, recombinant GA733-FcK protein levels
were investigated at different tissue positions during the growth
period. Quantitative immunoblot was applied to investigate the
change in GA733-FcK protein levels in the top, middle, and basal
leaves at 10, 12, 14, and 16 weeks. In the top leaves, the protein
level increased until 12 weeks and then decreased. The middle
leaves showed the highest GA733-FcK protein level (416 ng/mg
FW) compared to the others in terms of overall growth. It is spec-
ulated that the reduction of the recombinant GA733-FcK proteins
in top leaves is due to energy translocation for flower forma-
tion; at this time, biological energy generated in the top leaves
is sent to floral meristems. These results are consistent with the
previous report of decreased protein expression after flowering
(Woodson, 1987). The basal leaves showed stronger non-specific
band density compared to the top andmiddle leaves. These results
can be explained by the fact that basal leaves being more senes-
cent produce proteases to degrade recombinant proteins. This is
supported by much lower protein levels and less chloroplast in
yellow leaves compared with green leaves. The loss of chloro-
plast means the loss of energy production capacity resulting in
reduced protein production capacity (Munne-Bosch and Alegre,
2002). Therefore, these results are not unexpected. In all leaves,
the protein level increased until flowering and decreased after
that. Proteins degrade at higher rate with age (Woodson, 1987).
To study the effect of senescence on protein expression, different
expression patterns of the top, middle, and basal stem sections
harvested from plants at 18 weeks were analyzed with the densit-
ometry analysis. In stem, protein expression level declined from
the top to the base. It is speculated that the bottom section of
the stem has less biologically active cells compared to the top and
FIGURE 8 | Glycosylation analysis of GA733-FcK proteins isolated from
stem sections (top, middle, and base). The profiles of N-glycans released
from GA733-FcK were analyzed using HPLC profile of AB-labeled glycans.
The proposed glycan structures for each peak were designated. GlcNAc and
mannose are depicted with black square and white circle, respectively.
Relative N-glycan expression levels of GA733-FcK at different section of the
stem were analyzed by HPLC. The area is based on the absolute value of
peak intensities in HPLC analysis. Data represent means and standard errors.
Asterisks indicate significant differences (∗∗P < 0.05, ∗∗∗P < 0.01) inferred
with t-test.
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FIGURE 9 | Glycosylation analysis of GA733-FcK proteins isolated
from leaves (yellow and green). The profiles of N-glycans released
from GA733-FcK were quantified using HPLC profile of AB-labeled
glycans. Relative N-glycosylation levels of GA733-FcK in leaves of
different color were analyzed by reverse-phase HPLC. The area is
based on the absolute value of peak intensities in HPLC analysis.
GlcNAc, mannose, and xylose are depicted with black square, white
circle, and white star, respectively. Data represent means and standard
errors. Asterisks indicate significant differences (∗∗P < 0.05) inferred
with t-test.
middle stem sections. The low protein expression at the stem base
and in yellow leaves is due to their senescence. This study shows
that GA733-FcK protein levels at different leaf positions during
developmental stage were not harmonized with the mRNA levels;
instead, the amount of mRNAwas similar to the amount found at
10 weeks. Overall, the highest transcriptional level was observed
in the middle leaf at 16 weeks. It is speculated that low protein
level is due to reduced translation modification factors such as
RNA transport, post-transcriptional regulation, translation, and
protein modification process, even at high mRNA levels in plant
tissue. Furthermore, proteins degrade after translation due to
their senescence. Thus, proteins cannot be expressed with higher
levels of mRNA expression (Mullet and Klein, 1987). Therefore,
when the plant biomass is harvested for protein purification in
downstream processing, yellow leaves should not be included.
Although numerous previous studies have reported that the
glycosylation variation is associated with diverse environmental
factors including temperature and light conditions, the varia-
tions in glycosylation profiles with the developmental stage and
tissue positions are not fully understood. Our current results
support previous reports correlating the glycan structural dif-
ferences with aging and tissue positions (Stevens et al., 2000;
Elbers et al., 2001; Gleba et al., 2005; Jamal et al., 2009). All
leaf and stem samples had mostly oligo-mannose glycan struc-
tures, indicating that the KDEL ER retention signal efficiently
retained the glycoproteins with oligo-mannose (Ko et al., 2003).
In our current study, we were able to confirm the differences
in the glycan structure during developmental growth and aging.
In the top leaves, plant-specific glycan structure such as β(1,2)-
xylose increased between 14 and 16 weeks, whereas in the middle
leaf, plant-specific glycan structure decreased with aging. In the
basal leaves, the early growth period (10 weeks) showed the low-
est level of plant-specific glycan structures (Golgi type). The area
of N-glycan peaks of GA733-FcK proteins isolated from the top,
middle, and basal leaves varied with the growth period (10, 12,
14, and 16 weeks). The glycan peak area from the top leaves was
relatively smaller than the middle and basal leaves. Particularly
in the top leaves, the area increased until 12 weeks and dramat-
ically decreased afterwards, which was in contrast to the middle
leaves where the area increased until 14 weeks and then decreased.
However, in basal leaves, the area decreased until 14 weeks and
increased at 16 weeks. At 12 weeks, flowers near the top leaves
started blooming reaching full bloom at 14 weeks. It is speculated
that in plants, development and growth of floral organs require
large quantities of sugars from neighboring leaves to generate
required energy (Woodson, 1987). Thus, during flowering, phys-
iological changes result in reduction of protein and glycosylation
levels along with the increasing ratio Golgi/ER type N-glycans
in top leaves. This is probably due to the plant focusing its bio-
logical activities on development and growth of floral organs.
The amount of glycans on proteins was high in the middle and
basal leaves, which is consistent with a previous report confirm-
ing the accumulation of glycan in plants (Elbers et al., 2001). In
addition, changes in glycosylation patterns were analyzed at three
stem sections (top, middle, and base). When the plant growth
ceased, the glycosylation analysis of proteins extracted from the
stem showed no glycan structural difference in all three stem
sections. However, the glycan peak areas were quantitatively dif-
ferent among the top, middle, and base sections of the stem. The
peak area of the glycosylation amount of stems was smaller than
that of leaves. In contrast with the leaves, the glycosylation peak
area of the top stem was greater than in the middle and base
stem sections. This difference is probably due to the top por-
tion of stems having better sugar supply from leaves compared
with the other sections. Protein levels were different between
green and yellow leaves, whereas glycosylation level and glycan
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structure did not significantly differ between green and yellow
leaves, which is inconsistent with a previous study showing age
dependent glycosylation variation (Elbers et al., 2001). To under-
stand this discrepancy between the current and previous studies,
it should be noted that the glycoprotein GA733-FcK bore KDEL
ER retention signal, whereas the glycoprotein mouse IgG anti-
body examined in the previous study (De Boer et al., 1996) did
not have KDEL and were secreted through a default secretion
pathway. In this study, thus, the ratio Golgi/ER type glycan struc-
tures of proteins vary depending on the tendency of leakiness of
the glycoproteins.
The post-translational modification of a recombinant vaccine
candidate protein is of special importance for its immunogenicity.
N-Glycosylation of proteins in eukaryotic cells is accomplished
in two distinct organelles, the ER and Golgi (Helenius and Aebi,
2004; Ko et al., 2004). The glycan structures have an important
effect on therapeutic protein characteristics such as protein fold-
ing, in vivo half-life, and immunity (Lee et al., 2013). Since the
events of N-glycan modification in plant differ from those in
mammals, recombinant proteins produced in transgenic plants
will not be identical to mammalian glycoproteins. However, the
folding and assembly of recombinant proteins as well as the
transfer of an oligosaccharide precursor to N-glycosylation sites
can be correctly accomplished in transgenic plant systems (Chen
et al., 2005). The xylose and fucose are plant-specific glycan
structures that induce an allergic reaction when administered
to humans. This problem may be solved by the application of
KDEL (ER retention sequence) as the predominant expression
system in the production of therapeutic glycoproteins. KDEL
(ER retention sequence) attached in the ER to the C-terminal
retains a glycoprotein to avoid plant-specific glycan attachment
(Ko and Koprowski, 2005; Liu and Howell, 2010; Ruiz-May et al.,
2012).
In previous studies (Elbers et al., 2001; Jamal et al., 2013),
the protein expression and glycosylation were simply analyzed
at only leaf position of plant according to only temperature and
light conditions. Previously reported conditions were insufficient
to be used to optimize for mass production of the plant-derived
recombinant proteins. Although it has been known that the glyco-
sylation variation is associated with environmental factors such as
temperature and light conditions, the variations in glycosylation
profiles with the developmental stage (before and after flowering)
and tissue positions (leaf and stem) have not been fully studied.
Our current results are consistent with previous reports related
to the glycan structural differences with developmental stage and
tissue positions of plants. In this study, also we confirmed that
the stem tissues expressed the GA733-FcK with good amount of
proteins compared to the leaves. These results suggest stem tissues
including leaf tissues can be harvested to purify the recombinant
GA733-FcK. In addition, we confirmed that the glycan structures
with high mannose were homogeneous at the 12 weeks, but plant
specific glycan structures were observed after 14 weeks. These
results indicate that the farmers should harvest plants at least
before for 12 weeks (floral organ formation period). According to
these points, it is considered that the results obtained in this study
aremeaningful information for commercialization of GA733-FcK
producing plants.
In this study, the effect of aging and position of tissues was
identified by gene expression and glycosylation pattern. The
results described herein represent an overview of the effect of
aging and position of tissues that should be considered prior to
use of the plant-derived antigen in the large-scale production
of vaccine and harvesting. Taken together, we demonstrated the
variation in glycan structures and levels of recombinant anti-
gen antibody fusion protein GA733-FcK during flowering. This
is the first report of the ratio Golgi/ER type glycans of recombi-
nant glycoproteins increase in young leaves during flowering. The
correlation between glycosylation and energy dynamics during
flowering in plants warrants further detailed research.
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